This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
2018-08-14 reuters - 1
(Reuters) - Canada’s main stock index climbed on Tuesday as higher oil prices lifted energy stocks and concerns around Turkey’s currency crisis receded.
ACBFF HRNNF TD SU TWMJF WEED TD EGO SU HCG H TNTTF HMCBF CGC MFC ACB 0945 ELD CNQ MFC
VANCOUVER, British Columbia, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Golden Reign Resources Ltd. (TSX-V: GRR) (“Golden Reign”), Marlin Gold Mining Ltd. (TSX-V: MLN) (“Marlin”) and Sailfish Royalty Corp. (TSX-V: FISH) (“Sailfish”) are pleased to announce that Golden Reign and Marlin have entered into a definitive agreement (the “Arrangement Agreement”), unanimously approved by each of the boards of directors of Golden Reign and Marlin, pursuant to which Golden Reign and Marlin propose to complete the previously announced business combination whereby Golden Reign will acquire all of the issued and outstanding shares of Marlin (following completion of the Marlin Reorganization (as defined below) and satisfaction of all closing conditions of the business combination) by way of plan of arrangement (the “Transaction”).
MLN MLNGF EXK ELD SROYF KTN KOOYF EDR SLRZF EGO
2018-07-31 globenewswire - 1
VANCOUVER, British Columbia, July 31, 2018 (GLOBE NEWSWIRE) -- Golden Reign Resources Ltd. (TSX-V: GRR) (“Golden Reign”), Marlin Gold Mining Ltd. (TSX-V: MLN) (“Marlin”) and Sailfish Royalty Corp. (TSX-V: FISH) (“Sailfish”) are pleased to provide an update regarding the proposed business combination of Golden Reign’s wholly-owned San Albino-Murra Property in Nueva Segovia, Nicaragua and Marlin’s La Trinidad Mine in Sinaloa, Mexico.
MLN MLNGF ELD SROYF SLRZF EGO
2018-07-30 seekingalpha - 1
Eldorado Gold's (EGO) shares have performed reasonably well against the latest decline in gold price. However, investors and traders alike were waiting for significant upside catalyst in the company's second-quarter report. Unfortunately, this did not happen, although the report itself was good.
2018-07-27 seekingalpha - 1
Good morning, my name is Nicole, and I will be your conference operator today. At this time, I would like to welcome everyone to Eldorado Gold Corporation 2018 Q2 Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions] Thank you.
ELD DTK EGO
2018-07-20 reuters - 2
NEW YORK, July 20 (Reuters) - * The Toronto Stock Exchange’s S&P/TSX fell 107.55 points, or 0.65 percent, to 16,435.46, the index also closed the week down 0.65 percent, snapping a two-week winning streak. * Leading the index were Cameco Corp, up 4.1 percent, Eldorado Gold Corp, up 3.5 percent, and Labrador Iron Ore Royalty Corp , higher by 3.1 percent. * Lagging shares were West Fraser Timber Co Ltd, down 8.
TWMJF ACB ELD IFSPF WEED ACBFF BDRPF LIFZF CCJ CGC EGO
After a blockbuster start to the year, gold lost its luster plunging to one-year low thanks to a strengthening dollar and interest rate hikes. The yellow metal is down 10% from its January high, which confirms that the gold market has slipped into correction territory. Below, we have discussed various factors that have influenced the price of the gold and will continue to do so: Strong Dollar & Rate Hike The U.
NDMWF PVG ELD NAK CMCL PVG CMCL EGO
In this undated photo provided on Monday, Sept. 11, 2017, by Hellas Gold company, employees work inside a gold mine complex in Skouries, in the Halkidiki peninsula, northern Greece. (Hellas Gold via AP)
We are experiencing some temporary issues. The market data on this page are currently delayed. Please bear with us as we address this and restore your personalized lists.
WPM NGD GFI.WI ABX NEM NGDAF K GDX NGD SLW SLW ELD KGC GFI GFIOF EGO ABX
2018-08-20 - Asif
Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...
2018-08-20 - Asif
Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...
2018-08-20 - Asif
General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...